Which Vaccine Has Shown 100% Efficacy In Phase 3 Clinical Trials When Tested in Adolescents ?

The COVID-19 vaccine developed by Pfizer Inc and BioNTech has been granted emergency approval from the Food and Drug Administration for children aged 12 to 15 years old in the United States. The Center for Disease Control and Prevention highlighted that vaccination of children is crucial to help achieve herd immunity and to help protect the world against the virus.

With the increasing spread of the highly contagious strain of novel coronavirus, a vaccine for adolescents is considered a critical step to reduce the massive chaos caused by COVID-19. Meanwhile, the World Health Organization reported that they are reclassifying the highly infectious triple mutant COVID-19 strain spreading in India as a variant of concern for the globe. The Pfizer and BioNTech vaccine is the first COVID-19 vaccine authorized in the US for individuals in the 12 - 15 years age bracket. The FDA has concluded that the vaccine developed by Pfizer-BioNTech has met the statutory benchmarks to amend the Emergency Use Authority.


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.